HRC World Plc (CPH:HRC)

Ligand Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	1.91	0.93	1.55	1.99	0.04
Short-Term Investments	0.73	0.38	0.03	0.01	0.06
Cash & Short-Term Investments	2.64	1.32	1.58	2	0.1
Cash Growth	99.92%	-16.63%	-20.99%	1962.89%	-94.27%
Other Receivables	0.49	0.25	0.15	0.12	-
Receivables	0.49	0.25	0.15	0.12	-
Total Current Assets	3.12	1.57	1.73	2.12	0.1
Property, Plant & Equipment	0.17	0.16	0.19	0.05	-
Total Assets	3.29	1.73	1.92	2.17	0.1
Accounts Payable	1.71	0.03	0.05	0.11	0.3
Accrued Expenses	0.04	0.03	0.03	0.03	0.06
Current Portion of Leases	0.01	0.01	0.01	0.01	-
Other Current Liabilities	0.07	0.18	0.13	0.09	0.22
Total Current Liabilities	1.83	0.26	0.21	0.24	0.58
Long-Term Leases	0.04	0.01	0.03	0.04	-
Total Liabilities	1.87	0.27	0.24	0.28	0.58
Common Stock	1.85	1.85	1.85	1.85	1.85
Additional Paid-In Capital	1.81	1.81	1.81	1.81	1.81
Retained Earnings	-0.52	-0.47	-0.25	-0.04	-1.94
Treasury Stock	-14.52	-14.52	-14.52	-14.52	-15
Comprehensive Income & Other	12.8	12.8	12.8	12.8	12.8
Shareholders' Equity	1.42	1.46	1.68	1.89	-0.48
Total Liabilities & Equity	3.29	1.73	1.92	2.17	0.1
Total Debt	0.05	0.03	0.04	0.05	-
Net Cash (Debt)	2.59	1.29	1.54	1.95	0.1
Net Cash Growth	100.31%	-16.39%	-20.86%	1911.34%	-94.27%
Net Cash Per Share	0.02	0.01	0.01	0.01	0.00
Filing Date Shares Outstanding	138.85	138.85	138.85	138.85	138.85
Total Common Shares Outstanding	138.85	138.85	138.85	138.85	138.85
Working Capital	1.29	1.32	1.52	1.88	-0.48
Book Value Per Share	0.01	0.01	0.01	0.01	-0.00
Tangible Book Value	1.42	1.46	1.68	1.89	-0.48
Tangible Book Value Per Share	0.01	0.01	0.01	0.01	-0.00

Updated Dec 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.